Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.17 trillion and total revenue of $112.4 billion.
Market Cap
1.17T
Revenue
112.4B
Profits
-39.26B
PE Ratio
n/a
Profit Margin
-34.93%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.54B | 0.78% | 1,202,386 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.36B | 2.67% | 739,857 | 14.92B |
| 3 | ARGX | argenx SE | 50.31B | 1.62% | 433,264 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.45B | 0.63% | 1,012,335 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.83B | 5.32% | 386,039 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.12B | 2.62% | 2,946,296 | - |
| 7 | RPRX | Royalty Pharma plc | 30.07B | 0.56% | 3,888,116 | 2.44B |
| 8 | INSM | Insmed Incorporated | 29.59B | -1.69% | 2,302,230 | 606.42M |
| 9 | BNTX | BioNTech SE | 24.09B | -0.25% | 1,038,667 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.63B | 1.77% | 3,689,757 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.95B | 2.44% | 1,178,897 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.36B | 4.45% | 4,390,298 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.09B | 1.34% | 1,451,981 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.57B | 4.71% | 877,971 | 845.52M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.34B | 7.68% | 2,148,210 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.85B | 1.77% | 3,859,462 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.33B | -1.00% | 2,643,689 | 502.08M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.70B | 2.13% | 1,799,881 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.44B | 7.42% | 569,275 | 1.13B |
| 20 | EXEL | Exelixis, Inc. | 12.37B | 9.64% | 6,340,221 | 2.38B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.46B | -0.19% | 559,963 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.08B | 5.62% | 1,672,432 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 2.55% | 2,359,704 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.26B | 2.23% | 1,240,196 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.42B | 1.43% | 361,058 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.31B | -2.92% | 4,803,404 | 105.82M |
| 27 | IBRX | ImmunityBio, Inc. | 8.65B | 10.55% | 19,637,733 | 113.29M |
| 28 | KRYS | Krystal Biotech, Inc. | 8.52B | 1.55% | 288,688 | 417.30M |
| 29 | PCVX | Vaxcyte, Inc. | 8.24B | 2.62% | 1,600,525 | - |
| 30 | NUVL | Nuvalent, Inc. | 8.23B | 2.75% | 479,280 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.86B | 0.73% | 1,029,378 | 1.40B |
| 32 | TECH | Bio-Techne Corporation | 7.42B | -16.36% | 11,946,093 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.10B | 4.29% | 426,842 | 51.48M |
| 34 | CELC | Celcuity Inc. | 6.74B | -1.59% | 801,532 | - |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.71B | 4.04% | 1,005,786 | 569.61M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.69B | 4.80% | 989,857 | 74.06M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.62B | 4.66% | 1,244,794 | 217.17M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.34B | 2.80% | 711,407 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.32B | 1.50% | 413,676 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 6.20B | 16.26% | 6,589,142 | 700.35M |
| 41 | BLTE | Belite Bio, Inc | 6.15B | 1.19% | 173,941 | - |
| 42 | COGT | Cogent Biosciences, Inc. | 6.13B | -3.00% | 1,613,355 | - |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.18% | 874,082 | 15.00M |
| 44 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | - | 6,347,046 | - |
| 45 | CGON | CG Oncology, Inc. | 5.99B | 1.24% | 473,303 | 4.04M |
| 46 | IMVT | Immunovant, Inc. | 5.84B | 2.98% | 1,252,348 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | 1.52% | 724,088 | 7.50M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.62B | -0.06% | 921,104 | - |
| 49 | CORT | Corcept Therapeutics Incorporated | 5.60B | 1.60% | 1,534,565 | 769.10M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.52B | 2.35% | 637,933 | 1.73B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.41B | 0.95% | 1,671,448 | 812.03M |
| 52 | LEGN | Legend Biotech Corporation | 5.36B | 1.58% | 3,469,201 | 1.03B |
| 53 | CRSP | CRISPR Therapeutics AG | 5.31B | 5.15% | 2,529,832 | 4.10M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.26B | 0.37% | 3,719,972 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.94B | 0.20% | 466,912 | 1.34M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.66B | 0.11% | 185,398 | 268.09M |
| 57 | MANE | Veradermics, Incorporated | 4.52B | -4.38% | 901,621 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.37B | 2.36% | 1,341,451 | 7.70M |
| 59 | ORKA | Oruka Therapeutics, Inc. | 4.18B | 1.22% | 1,893,113 | - |
| 60 | TVTX | Travere Therapeutics, Inc. | 4.16B | -0.09% | 2,390,025 | 536.20M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.98B | -2.68% | 2,928,510 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.75B | 3.10% | 2,287,892 | - |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.73B | 0.63% | 87,568 | 803.79M |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.73B | -1.10% | 1,815,441 | 588.99M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 3.68B | -3.89% | 3,577,887 | 1.10B |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.56B | 3.82% | 1,053,583 | 22.50M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.41B | -2.40% | 1,475,615 | 62.38M |
| 68 | ERAS | Erasca, Inc. | 3.39B | 9.11% | 6,044,449 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.27B | -0.23% | 1,825,430 | 236.00M |
| 70 | ALMS | Alumis Inc. | 3.24B | -2.41% | 560,549 | 24.05M |
| 71 | BEAM | Beam Therapeutics Inc. | 3.24B | 11.90% | 2,187,808 | 139.74M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.24B | 7.88% | 2,199,216 | - |
| 73 | KLRA | Kailera Therapeutics, Inc. | 3.20B | 1.81% | 531,190 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.11B | 7.84% | 1,720,219 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.02B | 3.20% | 1,383,544 | 415.62M |
| 76 | GPCR | Structure Therapeutics Inc. | 2.90B | -0.63% | 867,352 | - |
| 77 | NKTR | Nektar Therapeutics | 2.87B | 1.11% | 568,024 | 55.23M |
| 78 | KOD | Kodiak Sciences Inc. | 2.85B | 7.57% | 387,960 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | -0.43% | 940,426 | 535.08M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.04% | 1,956,727 | 190.41M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.70B | 1.57% | 534,788 | 1.55M |
| 82 | IMNM | Immunome, Inc. | 2.64B | 0.69% | 786,862 | 6.94M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.62B | 6.01% | 825,276 | - |
| 84 | IRON | Disc Medicine, Inc. | 2.62B | 1.57% | 378,750 | - |
| 85 | DFTX | Definium Therapeutics, Inc. | 2.55B | 4.55% | 1,512,867 | - |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 3.68% | 3,454,791 | 670.00M |
| 87 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.21% | 898,915 | 225.27M |
| 88 | ELVN | Enliven Therapeutics, Inc. | 2.51B | -0.91% | 370,282 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 2.87% | 1,002,965 | - |
| 90 | RLAY | Relay Therapeutics, Inc. | 2.48B | -0.62% | 3,440,311 | 10.68M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.43B | 5.69% | 4,784,414 | 2.18B |
| 92 | ZLAB | Zai Lab Limited | 2.36B | 0.14% | 1,055,115 | 460.16M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.34B | -1.66% | 12,973,208 | 509.86M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.13B | - | 3,791,930 | 52.04M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 1.28% | 715,149 | 283.06M |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.07B | 0.97% | 575,030 | 184.42M |
| 97 | INBX | Inhibrx Biosciences, Inc. | 2.07B | 10.71% | 774,323 | 1.30M |
| 98 | ZYME | Zymeworks Inc. | 2.04B | 3.49% | 427,423 | 105.97M |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -2.73% | 1,729,058 | - |
| 100 | TYRA | Tyra Biosciences, Inc. | 2.01B | -0.38% | 526,265 | - |
| 101 | TSHA | Taysha Gene Therapies, Inc. | 2.01B | 0.58% | 4,137,700 | 7.47M |
| 102 | CAPR | Capricor Therapeutics, Inc. | 1.99B | 4.31% | 710,742 | 11.13M |
| 103 | AAPG | Ascentage Pharma Group International | 1.99B | -1.51% | 5,205 | 82.08M |
| 104 | NBTX | Nanobiotix S.A. | 1.98B | 20.39% | 127,989 | 38.27M |
| 105 | PHVS | Pharvaris N.V. | 1.97B | 0.30% | 409,454 | - |
| 106 | MESO | Mesoblast Limited | 1.96B | 0.13% | 221,145 | 65.38M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.95B | 5.66% | 311,288 | - |
| 108 | GENB | Generate Biomedicines, Inc. | 1.95B | -0.78% | 204,585 | 31.89M |
| 109 | ANAB | AnaptysBio, Inc. | 1.94B | -2.77% | 681,036 | 234.60M |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.94B | 4.06% | 3,808,533 | 67.67M |
| 111 | GLPG | Galapagos NV | 1.91B | 1.48% | 91,759 | 1.31B |
| 112 | HRMY | Harmony Biosciences Holdings, Inc. | 1.90B | 1.36% | 749,543 | 868.45M |
| 113 | VCEL | Vericel Corporation | 1.87B | -0.08% | 828,634 | 276.26M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 0.54% | 274,439 | - |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | 2.74% | 1,699,466 | 217.17M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 1.78% | 17,691,359 | 66.41M |
| 117 | VRDN | Viridian Therapeutics, Inc. | 1.81B | -6.51% | 7,759,395 | 70.92M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 4.13% | 213,298 | - |
| 119 | NUVB | Nuvation Bio Inc. | 1.75B | 4.35% | 6,331,902 | 143.05M |
| 120 | ARDX | Ardelyx, Inc. | 1.75B | -0.42% | 4,663,168 | 427.68M |
| 121 | OCS | Oculis Holding AG | 1.75B | 6.59% | 263,897 | 1.51M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 1.69% | 977,088 | 71.78M |
| 123 | IOVA | Iovance Biotherapeutics, Inc. | 1.68B | 2.76% | 17,051,723 | 263.50M |
| 124 | INVA | Innoviva, Inc. | 1.67B | -0.57% | 617,503 | 420.69M |
| 125 | VIR | Vir Biotechnology, Inc. | 1.66B | 2.80% | 1,593,948 | 68.56M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.63B | 5.37% | 1,136,531 | 123.67M |
| 127 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -0.85% | 1,108,640 | 66.05M |
| 128 | IMCR | Immunocore Holdings plc | 1.56B | 6.55% | 330,317 | 412.81M |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.56B | 2.68% | 325,001 | - |
| 130 | PGEN | Precigen, Inc. | 1.56B | 1.62% | 3,739,192 | 9.68M |
| 131 | IMTX | Immatics N.V. | 1.54B | 5.11% | 747,883 | 56.67M |
| 132 | NVAX | Novavax, Inc. | 1.54B | 15.56% | 16,482,984 | 596.34M |
| 133 | ATAI | AtaiBeckley Inc. | 1.53B | 4.25% | 3,940,484 | 4.09M |
| 134 | MBX | MBX Biosciences, Inc. | 1.53B | 8.51% | 465,679 | - |
| 135 | ABCL | AbCellera Biologics Inc. | 1.53B | 8.15% | 7,702,538 | 75.13M |
| 136 | BHVN | Biohaven Ltd. | 1.51B | 3.40% | 2,028,176 | - |
| 137 | DMRA | Damora Therapeutics, Inc. | 1.49B | -0.72% | 125,355 | - |
| 138 | FTRE | Fortrea Holdings Inc. | 1.48B | 7.64% | 2,868,919 | 2.71B |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.34% | 325,051 | 2.50M |
| 140 | QURE | uniQure N.V. | 1.44B | 7.84% | 3,552,288 | 18.09M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.40B | 1.53% | 4,063,562 | 71.80M |
| 142 | GHRS | GH Research PLC | 1.39B | 5.45% | 374,581 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -0.70% | 398,691 | - |
| 144 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.04% | 6,491,196 | 73.62M |
| 145 | SVRA | Savara Inc. | 1.34B | 0.38% | 1,000,721 | - |
| 146 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 3.76% | 561,801 | - |
| 147 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 4.01% | 267,989 | - |
| 148 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | -1.59% | 1,003,176 | - |
| 149 | URGN | UroGen Pharma Ltd. | 1.28B | 10.16% | 2,834,615 | 140.49M |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.27B | 4.06% | 548,969 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.51% | 638,154 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.24B | 0.34% | 352,878 | 10.00M |
| 153 | DBVT | DBV Technologies S.A. | 1.20B | 3.13% | 291,310 | 5.74M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.16B | 1.02% | 673,816 | - |
| 155 | PHAR | Pharming Group N.V. | 1.16B | 1.42% | 4,078 | 369.49M |
| 156 | EYPT | EyePoint, Inc. | 1.12B | -2.91% | 1,214,782 | 7.61M |
| 157 | SEPN | Septerna, Inc. | 1.11B | 2.40% | 308,477 | 45.95M |
| 158 | IVA | Inventiva S.A. | 1.11B | -0.37% | 72,143 | 7.94M |
| 159 | AKTS | Aktis Oncology, Inc. | 1.11B | 3.03% | 163,101 | 6.50M |
| 160 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | 0.04% | 569,715 | - |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 2.25% | 1,952,070 | 291.85M |
| 162 | MNKD | MannKind Corporation | 1.10B | 24.48% | 36,837,614 | 360.78M |
| 163 | OMER | Omeros Corporation | 1.07B | 0.41% | 539,605 | - |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | 2.34% | 3,555,411 | 185.74M |
| 165 | GERN | Geron Corporation | 1.01B | -4.24% | 21,462,828 | 196.12M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.01B | 4.30% | 3,566,393 | - |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.56% | 909,189 | 204.89M |
| 168 | XNCR | Xencor, Inc. | 964.40M | 1.25% | 819,460 | 97.36M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 962.71M | -2.82% | 1,270,805 | - |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | 950.34M | 5.75% | 3,544,641 | - |
| 171 | ANNX | Annexon, Inc. | 926.29M | -0.35% | 1,351,458 | - |
| 172 | ABSI | Absci Corporation | 924.91M | 6.06% | 6,849,901 | 2.80M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 921.48M | 2.77% | 3,171,218 | 84.28M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 921.16M | 0.33% | 886,271 | - |
| 175 | LBRX | LB Pharmaceuticals Inc | 917.62M | -2.68% | 218,404 | - |
| 176 | MGTX | MeiraGTx Holdings plc | 916.32M | 1.54% | 494,713 | 81.39M |
| 177 | DSGN | Design Therapeutics, Inc. | 908.75M | 8.50% | 783,482 | - |
| 178 | CTMX | CytomX Therapeutics, Inc. | 899.08M | 1.23% | 2,628,426 | 76.20M |
| 179 | JANX | Janux Therapeutics, Inc. | 891.26M | 2.02% | 952,461 | 10.00M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 874.60M | 3.11% | 144,766 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 872.29M | 1.26% | 313,013 | 107.46M |
| 182 | ABUS | Arbutus Biopharma Corporation | 870.47M | 0.45% | 1,008,825 | 14.08M |
| 183 | VOR | Vor Biopharma Inc. | 861.55M | 2.45% | 626,656 | - |
| 184 | ANRO | Alto Neuroscience, Inc. | 858.44M | -3.77% | 352,801 | - |
| 185 | EVMN | Evommune, Inc. | 858.32M | -1.37% | 521,163 | 13.00M |
| 186 | KURA | Kura Oncology, Inc. | 848.57M | 2.91% | 1,066,237 | 67.48M |
| 187 | SPTX | Seaport Therapeutics, Inc. | 848.45M | - | 498,649 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 837.50M | 2.64% | 161,612 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 824.42M | 6.94% | 833,965 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 794.59M | 6.45% | 7,352,979 | 22.00K |
| 191 | GYRE | Gyre Therapeutics, Inc. | 779.83M | 3.34% | 131,565 | 116.59M |
| 192 | SLDB | Solid Biosciences Inc. | 708.58M | 4.35% | 2,262,641 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 707.72M | -3.76% | 1,077,876 | - |
| 194 | TRAX | First Tracks Biotherapeutics, Inc. | 703.66M | -4.44% | 654,317 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 677.89M | -3.03% | 2,210,354 | 49.80M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 667.99M | 2.71% | 401,703 | - |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 667.59M | 0.63% | 997,371 | 7.83M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 666.67M | 0.73% | 168,349 | - |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 665.04M | 6.03% | 2,071,932 | 122.29M |
| 200 | ARVN | Arvinas, Inc. | 656.24M | -3.30% | 1,142,266 | 262.60M |
| 201 | FBRX | Forte Biosciences, Inc. | 649.16M | -2.82% | 109,005 | - |
| 202 | ALT | Altimmune, Inc. | 633.09M | 6.54% | 4,096,721 | 41.00K |
| 203 | CRMD | CorMedix Inc. | 631.35M | 4.14% | 1,164,884 | 311.71M |
| 204 | STRO | Sutro Biopharma, Inc. | 624.44M | 0.99% | 149,166 | 102.48M |
| 205 | CABA | Cabaletta Bio, Inc. | 608.18M | -10.12% | 6,736,509 | - |
| 206 | PRME | Prime Medicine, Inc. | 604.06M | 0.59% | 2,698,945 | 4.63M |
| 207 | AGMB | AgomAb Therapeutics NV | 602.80M | -2.08% | 149,882 | - |
| 208 | PRTA | Prothena Corporation plc | 601.85M | -0.09% | 333,876 | 9.68M |
| 209 | CBIO | Crescent Biopharma, Inc. | 600.12M | -0.11% | 269,422 | 11.88M |
| 210 | ENGN | enGene Therapeutics Inc. | 592.86M | 12.17% | 388,695 | - |
| 211 | PROK | ProKidney Corp. | 591.84M | 2.08% | 580,605 | 893.00K |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 586.73M | 3.81% | 1,907,724 | 170.16M |
| 213 | TRDA | Entrada Therapeutics, Inc. | 585.68M | 1.78% | 416,167 | 25.42M |
| 214 | CLYM | Climb Bio, Inc. | 583.73M | 6.72% | 1,334,305 | - |
| 215 | AVTX | Avalo Therapeutics, Inc. | 582.64M | 34.13% | 22,460,461 | 59.00K |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 573.22M | 2.82% | 588,142 | - |
| 217 | ANL | Adlai Nortye Ltd. | 570.80M | -4.42% | 242,354 | 5.00M |
| 218 | CADL | Candel Therapeutics, Inc. | 558.87M | -0.52% | 1,831,107 | - |
| 219 | CTNM | Contineum Therapeutics, Inc. | 557.80M | 3.82% | 243,159 | - |
| 220 | IMMX | Immix Biopharma, Inc. | 547.08M | 7.95% | 1,119,797 | - |
| 221 | TECX | Tectonic Therapeutic, Inc. | 546.98M | -1.16% | 237,399 | - |
| 222 | MDXG | MiMedx Group, Inc. | 545.14M | 0.55% | 1,574,320 | 389.42M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 544.70M | 7.31% | 711,285 | 85.21M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 539.76M | -3.02% | 230,424 | - |
| 225 | AURA | Aura Biosciences, Inc. | 532.22M | -6.85% | 1,102,997 | - |
| 226 | VSTM | Verastem, Inc. | 527.94M | 0.84% | 1,896,314 | 30.91M |
| 227 | RGNX | REGENXBIO Inc. | 527.53M | 10.85% | 1,456,341 | 170.44M |
| 228 | SGMT | Sagimet Biosciences Inc. | 517.48M | 8.55% | 1,582,961 | - |
| 229 | VALN | Valneva SE | 516.63M | 2.27% | 41,552 | 205.07M |
| 230 | STTK | Shattuck Labs, Inc. | 504.89M | 2.14% | 441,798 | 1.00M |
| 231 | NGNE | Neurogene Inc. | 504.86M | 11.71% | 341,496 | 925.00K |
| 232 | UPB | Upstream Bio, Inc. | 500.12M | 0.77% | 409,195 | 2.85M |
| 233 | ASMB | Assembly Biosciences, Inc. | 498.39M | 6.13% | 156,303 | 72.30M |
| 234 | XOMA | XOMA Royalty Corporation | 495.69M | -0.14% | 164,148 | 52.15M |
| 235 | RIGL | Rigel Pharmaceuticals, Inc. | 493.45M | -5.06% | 849,650 | 299.77M |
| 236 | OCGN | Ocugen, Inc. | 492.54M | -2.35% | 15,684,857 | 4.47M |
| 237 | ADCT | ADC Therapeutics SA | 490.96M | 2.66% | 2,630,420 | 79.18M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 486.67M | 3.64% | 708,213 | 12.14M |
| 239 | LYEL | Lyell Immunopharma, Inc. | 486.48M | 1.12% | 36,445 | 36.00K |
| 240 | OVID | Ovid Therapeutics Inc. | 481.04M | -1.77% | 2,572,452 | 7.25M |
| 241 | FULC | Fulcrum Therapeutics, Inc. | 473.76M | 1.28% | 546,676 | 80.00M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.01M | 4.26% | 228,262 | - |
| 243 | ZURA | Zura Bio Limited | 463.97M | -5.60% | 1,456,365 | - |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 461.56M | 4.53% | 616,888 | - |
| 245 | AUTL | Autolus Therapeutics plc | 452.44M | 3.66% | 2,173,121 | 75.39M |
| 246 | AVIR | Atea Pharmaceuticals, Inc. | 452.15M | 0.89% | 271,153 | - |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 447.40M | 0.68% | 1,690,211 | 217.78M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 442.25M | 5.25% | 344,924 | 66.98M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 431.11M | 3.49% | 2,415,145 | - |
| 250 | BNTC | Benitec Biopharma Inc. | 430.58M | 3.03% | 115,529 | - |
| 251 | MNPR | Monopar Therapeutics Inc. | 427.36M | 12.27% | 288,548 | - |
| 252 | NMRA | Neumora Therapeutics, Inc. | 425.66M | 1.30% | 1,708,834 | - |
| 253 | PRTC | PureTech Health plc | 425.06M | 1.89% | 18,676 | 4.66M |
| 254 | IPSC | Century Therapeutics, Inc. | 422.03M | 2.18% | 745,902 | 109.16M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 421.41M | 9.04% | 3,069,165 | - |
| 256 | IVVD | Invivyd, Inc. | 412.89M | 5.04% | 2,734,761 | 53.43M |
| 257 | NAGE | Niagen Bioscience, Inc. | 398.83M | 3.11% | 1,280,167 | 130.42M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 398.23M | 4.29% | 651,686 | 9.01M |
| 259 | VTVT | vTv Therapeutics Inc. | 393.13M | -0.38% | 17,148 | 17.00K |
| 260 | SRZN | Surrozen, Inc. | 392.04M | 4.56% | 136,190 | 3.48M |
| 261 | PBYI | Puma Biotechnology, Inc. | 379.14M | 1.36% | 484,981 | 228.37M |
| 262 | IRD | Opus Genetics, Inc. | 375.58M | 1.15% | 638,267 | 14.20M |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 373.61M | 2.80% | 241,518 | - |
| 264 | YDES | YD Bio Limited | 365.23M | 0.85% | 2,913 | 510.36K |
| 265 | BCYC | Bicycle Therapeutics plc | 358.99M | 5.10% | 780,369 | 63.50M |
| 266 | LCTX | Lineage Cell Therapeutics, Inc. | 356.20M | -2.05% | 805,832 | 14.56M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 351.31M | 4.32% | 184,782 | - |
| 268 | SLN | Silence Therapeutics plc | 347.64M | 3.08% | 381,013 | 559.00K |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 342.61M | 4.15% | 668,942 | 1.00 |
| 270 | ABEO | Abeona Therapeutics Inc. | 341.86M | 3.09% | 1,837,687 | 5.82M |
| 271 | CMPX | Compass Therapeutics, Inc. | 336.76M | -4.10% | 11,551,812 | 850.00K |
| 272 | IMRX | Immuneering Corporation | 335.78M | -2.81% | 1,058,510 | - |
| 273 | PALI | Palisade Bio, Inc. | 334.85M | 1.52% | 1,847,044 | - |
| 274 | ARMP | Armata Pharmaceuticals, Inc. | 332.46M | -3.21% | 53,480 | 4.90M |
| 275 | RZLT | Rezolute, Inc. | 326.16M | -4.56% | 1,570,807 | - |
| 276 | GLSI | Greenwich LifeSciences, Inc. | 319.49M | 3.41% | 89,799 | - |
| 277 | NGEN | NervGen Pharma Corp. | 314.82M | 3.18% | 130,277 | - |
| 278 | TARA | Protara Therapeutics, Inc. | 311.64M | 4.62% | 577,026 | - |
| 279 | EDIT | Editas Medicine, Inc. | 310.85M | 4.44% | 1,245,236 | 38.69M |
| 280 | AVXL | Anavex Life Sciences Corp. | 309.52M | -0.60% | 1,088,181 | - |
| 281 | ARTV | Artiva Biotherapeutics, Inc. | 306.24M | 16.89% | 308,378 | 251.00K |
| 282 | LENZ | LENZ Therapeutics, Inc. | 303.51M | 6.73% | 1,141,144 | 19.09M |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 296.49M | 2.20% | 834,094 | 26.87M |
| 284 | ACIU | AC Immune SA | 294.63M | -1.33% | 345,677 | 4.62M |
| 285 | ELDN | Eledon Pharmaceuticals, Inc. | 288.67M | 0.53% | 1,961,132 | - |
| 286 | CCCC | C4 Therapeutics, Inc. | 285.90M | -1.35% | 1,315,928 | 35.95M |
| 287 | REPL | Replimune Group, Inc. | 284.05M | 19.86% | 7,056,752 | - |
| 288 | ALEC | Alector, Inc. | 283.63M | - | 470,645 | 21.05M |
| 289 | CLLS | Cellectis S.A. | 282.89M | 5.05% | 17,630 | 79.59M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 281.23M | 8.29% | 691,044 | - |
| 291 | HELP | Cybin Inc. | 277.20M | 6.13% | 716,024 | - |
| 292 | FHTX | Foghorn Therapeutics Inc. | 274.72M | 0.86% | 84,910 | 30.91M |
| 293 | NERV | Minerva Neurosciences, Inc. | 273.14M | -0.32% | 87,913 | - |
| 294 | CHRS | Coherus Oncology, Inc. | 269.88M | -2.23% | 1,288,325 | 42.17M |
| 295 | SABS | SAB Biotherapeutics, Inc. | 267.05M | 3.26% | 710,946 | 114.70K |
| 296 | FATE | Fate Therapeutics, Inc. | 266.29M | -2.97% | 5,872,774 | 6.65M |
| 297 | NVCT | Nuvectis Pharma, Inc. | 265.26M | 2.99% | 176,074 | - |
| 298 | CGEN | Compugen Ltd. | 260.97M | 1.47% | 405,585 | 72.76M |
| 299 | NBP | NovaBridge Biosciences | 260.21M | -5.46% | 2,178,601 | - |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 259.50M | 8.56% | 416,097 | 82.03M |
| 301 | ACHV | Achieve Life Sciences, Inc. | 255.55M | 5.26% | 1,288,509 | - |
| 302 | VYGR | Voyager Therapeutics, Inc. | 251.94M | 6.92% | 834,181 | 40.37M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 249.24M | 6.85% | 240,800 | 44.64M |
| 304 | HRTX | Heron Therapeutics, Inc. | 247.12M | 6.50% | 4,618,440 | 154.90M |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 245.04M | 12.86% | 278,382 | 1.78M |
| 306 | CDXS | Codexis, Inc. | 241.71M | -3.27% | 1,811,357 | 70.39M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 241.62M | 4.79% | 1,359,838 | 1.55M |
| 308 | OBIO | Orchestra BioMed Holdings, Inc. | 240.52M | 2.49% | 445,581 | 33.48M |
| 309 | ADAG | Adagene Inc. | 238.52M | -0.28% | 128,782 | 7.67M |
| 310 | NKTX | Nkarta, Inc. | 236.69M | 7.79% | 1,321,055 | - |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 233.41M | -3.21% | 16,002 | 19.39M |
| 312 | KROS | Keros Therapeutics, Inc. | 233.10M | 0.08% | 305,465 | 244.06M |
| 313 | MDWD | MediWound Ltd. | 223.24M | -0.40% | 63,991 | 16.96M |
| 314 | CNTX | Context Therapeutics Inc. | 221.43M | -1.23% | 506,822 | - |
| 315 | HUMA | Humacyte, Inc. | 218.31M | 9.03% | 6,062,853 | 2.04M |
| 316 | CAMP | Camp4 Therapeutics Corporation | 210.82M | 2.01% | 31,845 | 3.50M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 208.68M | 8.81% | 879,832 | 13.11M |
| 318 | OABI | OmniAb, Inc. | 207.04M | 2.14% | 577,268 | 18.67M |
| 319 | UNCY | Unicycive Therapeutics, Inc. | 205.18M | 0.62% | 716,671 | - |
| 320 | WHWK | Whitehawk Therapeutics, Inc. | 205.13M | -1.43% | 147,173 | 7.15M |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 203.34M | -4.14% | 180,402 | 146.07M |
| 322 | RNA | Atrium Therapeutics, Inc. | 203.09M | 1.39% | 378,909 | 18.62M |
| 323 | ENLV | Enlivex Ltd. | 200.79M | 1.61% | 272,509 | - |
| 324 | DTIL | Precision BioSciences, Inc. | 194.04M | 0.94% | 332,401 | 45.07M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 193.68M | 2.34% | 630,447 | - |
| 326 | KRRO | Korro Bio, Inc. | 192.40M | 5.96% | 91,751 | 6.39M |
| 327 | ELTX | Elicio Therapeutics, Inc. | 192.24M | -1.32% | 97,060 | - |
| 328 | CRBU | Caribou Biosciences, Inc. | 191.60M | 1.04% | 985,879 | 11.16M |
| 329 | MGNX | MacroGenics, Inc. | 191.32M | -4.44% | 1,156,728 | 149.50M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 187.61M | 2.80% | 183,533 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 185.62M | 1.98% | 264,256 | - |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 181.30M | -0.93% | 344,038 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 181.22M | 5.52% | 491,929 | 19.19M |
| 334 | IFRX | InflaRx N.V. | 180.73M | 26.90% | 18,260,437 | 33.82K |
| 335 | PLYX | Polaryx Therapeutics, Inc. | 179.90M | -16.30% | 336,579 | - |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 171.47M | 4.76% | 4,908,575 | - |
| 337 | ANTX | AN2 Therapeutics, Inc. | 167.38M | -0.85% | 182,403 | - |
| 338 | MENS | Jyong Biotech Ltd. | 165.34M | 3.86% | 38,541 | - |
| 339 | OKUR | OnKure Therapeutics, Inc. | 164.41M | -9.96% | 185,116 | - |
| 340 | PLX | Protalix BioTherapeutics, Inc. | 162.75M | 3.06% | 1,205,376 | 52.74M |
| 341 | BDTX | Black Diamond Therapeutics, Inc. | 161.55M | -1.74% | 993,190 | 70.00M |
| 342 | HURA | TuHURA Biosciences, Inc. | 161.49M | 9.48% | 1,295,903 | - |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 158.55M | -1.51% | 136,278 | 2.00M |
| 344 | KZIA | Kazia Therapeutics Limited | 158.15M | 2.90% | 171,561 | 1.27M |
| 345 | MOLN | Molecular Partners AG | 157.48M | 0.83% | 2,469 | 856.30K |
| 346 | SPRB | Spruce Biosciences, Inc. | 156.38M | -2.48% | 44,438 | 697.00K |
| 347 | IMUX | Immunic, Inc. | 149.87M | -2.30% | 462,208 | - |
| 348 | AGEN | Agenus Inc. | 149.37M | -6.71% | 1,548,158 | 114.20M |
| 349 | GALT | Galectin Therapeutics Inc. | 148.11M | 0.90% | 382,988 | - |
| 350 | SPRO | Spero Therapeutics, Inc. | 146.49M | 4.55% | 620,275 | 66.80M |
| 351 | VRCA | Verrica Pharmaceuticals Inc. | 144.82M | 17.74% | 475,290 | 35.58M |
| 352 | PYXS | Pyxis Oncology, Inc. | 144.51M | 25.68% | 1,846,465 | 13.86M |
| 353 | CNTB | Connect Biopharma Holdings Limited | 140.17M | 0.40% | 67,476 | 64.00K |
| 354 | IPHA | Innate Pharma S.A. | 139.82M | 7.86% | 15,986 | 10.57M |
| 355 | ACOG | Alpha Cognition Inc. | 138.92M | - | 32,208 | 10.22M |
| 356 | EQ | Equillium, Inc. | 137.20M | 4.83% | 184,869 | 4.39M |
| 357 | ALPS | Alps Group Inc | 136.93M | -0.77% | 40,826 | 3.74M |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 133.75M | 6.41% | 86,534 | 39.99K |
| 359 | EDSA | Edesa Biotech, Inc. | 133.20M | -3.04% | 375,389 | - |
| 360 | AARD | Aardvark Therapeutics, Inc. | 128.50M | 7.68% | 137,321 | - |
| 361 | PEPG | PepGen Inc. | 127.62M | -4.40% | 1,932,313 | - |
| 362 | GNLX | Genelux Corporation | 127.35M | 3.61% | 211,778 | 8.00K |
| 363 | CBUS | Cibus, Inc. | 121.29M | 3.25% | 349,772 | 3.64M |
| 364 | GUTS | Fractyl Health, Inc. | 116.64M | 5.95% | 1,124,104 | 3.00K |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 116.34M | -4.53% | 106,150 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 115.68M | 5.26% | 1,845,782 | - |
| 367 | CRDF | Cardiff Oncology, Inc. | 114.86M | 4.35% | 1,052,929 | 593.00K |
| 368 | TTRX | Turn Therapeutics Inc. | 113.05M | 2.57% | 12,808 | - |
| 369 | CUE | Cue Biopharma, Inc. | 110.62M | -2.75% | 813,387 | 27.47M |
| 370 | CGTX | Cognition Therapeutics, Inc. | 109.91M | -0.81% | 864,475 | - |
| 371 | KALA | KALA BIO, Inc. | 106.98M | 2.68% | 1,273,939 | - |
| 372 | ONCY | Oncolytics Biotech Inc. | 106.84M | 0.55% | 1,235,053 | - |
| 373 | SEER | Seer, Inc. | 106.64M | 1.61% | 205,976 | 16.58M |
| 374 | VANI | Vivani Medical, Inc. | 105.81M | - | 176,361 | - |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 104.96M | 1.16% | 1,148,148 | - |
| 376 | ANIX | Anixa Biosciences, Inc. | 102.60M | 2.00% | 101,325 | - |
| 377 | ATYR | aTyr Pharma, Inc. | 101.97M | 23.49% | 4,184,094 | 190.00K |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 101.60M | 8.77% | 3,064,906 | 65.34K |
| 379 | NRXS | NeurAxis, Inc. | 101.36M | 1.38% | 301,990 | 3.57M |
| 380 | NRXP | NRx Pharmaceuticals, Inc. | 100.76M | 0.33% | 1,082,464 | 1.23M |
| 381 | COYA | Coya Therapeutics, Inc. | 99.46M | -0.24% | 74,540 | 7.95M |
| 382 | PMN | ProMIS Neurosciences, Inc. | 98.64M | -0.54% | 28,081 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 95.83M | 8.62% | 1,020,573 | 1.63M |
| 384 | QTTB | Q32 Bio Inc. | 92.75M | 6.42% | 342,462 | 53.74M |
| 385 | ACET | Adicet Bio, Inc. | 91.91M | 0.47% | 113,019 | - |
| 386 | RNTX | Rein Therapeutics Inc. | 91.31M | 14.71% | 3,572,647 | - |
| 387 | EXOZ | eXoZymes, Inc. | 89.37M | 6.57% | 1,772 | -700.00 |
| 388 | LONA | LeonaBio, Inc. | 88.49M | -2.18% | 19,698 | - |
| 389 | OKYO | OKYO Pharma Limited | 88.17M | 5.00% | 155,506 | - |
| 390 | PYPD | PolyPid Ltd. | 85.49M | -0.44% | 28,082 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 83.89M | -1.77% | 17,883 | 16.80M |
| 392 | CSBR | Champions Oncology, Inc. | 83.04M | 0.17% | 17,919 | 57.95M |
| 393 | ANVS | Annovis Bio, Inc. | 82.88M | 5.73% | 725,480 | - |
| 394 | GOSS | Gossamer Bio, Inc. | 82.19M | 4.23% | 4,552,106 | 48.47M |
| 395 | FBIO | Fortress Biotech, Inc. | 82.12M | 3.66% | 340,650 | 63.26M |
| 396 | MAIA | MAIA Biotechnology, Inc. | 81.91M | -2.88% | 1,012,675 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 80.98M | 0.48% | 424,776 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 80.68M | 2.14% | 434,042 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 78.70M | -0.22% | 14,990 | 4.43M |
| 400 | ICCC | ImmuCell Corporation | 78.35M | -2.59% | 54,453 | 27.64M |
| 401 | XBIT | XBiotech Inc. | 77.74M | - | 25,519 | - |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 77.33M | 5.84% | 214,788 | - |
| 403 | MCRB | Seres Therapeutics, Inc. | 77.06M | 6.67% | 109,821 | 1.15M |
| 404 | RLYB | Rallybio Corporation | 77.02M | 1.96% | 239,296 | 858.00K |
| 405 | PLRX | Pliant Therapeutics, Inc. | 76.16M | 1.65% | 561,870 | - |
| 406 | TCRX | TScan Therapeutics, Inc. | 75.13M | 3.31% | 1,067,369 | 9.14M |
| 407 | OSTX | OS Therapies Incorporated | 72.73M | - | 468,672 | - |
| 408 | MNOV | MediciNova, Inc. | 71.37M | 2.84% | 48,282 | 409.66K |
| 409 | ACTU | Actuate Therapeutics, Inc. | 70.90M | -2.61% | 104,708 | - |
| 410 | FLNA | Filana Therapeutics, Inc. | 69.56M | 4.35% | 477,212 | - |
| 411 | IBO | Impact BioMedical Inc. | 68.47M | -1.24% | 56,323 | 32.00K |
| 412 | IMA | ImageneBio, Inc. | 68.00M | 4.29% | 17,165 | 800.00K |
| 413 | IBIO | iBio, Inc. | 63.97M | 9.94% | 1,923,479 | 300.00K |
| 414 | BYSI | BeyondSpring Inc. | 63.74M | 7.64% | 15,123 | 1.88M |
| 415 | HYFT | MindWalk Holdings Corp. | 63.08M | 1.60% | 48,754 | 20.70M |
| 416 | IMMP | Immutep Limited | 62.92M | -3.74% | 757,811 | 5.28M |
| 417 | CING | Cingulate Inc. | 61.98M | 7.03% | 339,120 | - |
| 418 | PDSB | PDS Biotechnology Corporation | 59.16M | - | 429,584 | - |
| 419 | ENTX | Entera Bio Ltd. | 58.28M | 7.76% | 102,371 | 42.00K |
| 420 | INKT | MiNK Therapeutics, Inc. | 55.67M | -2.86% | 11,224 | - |
| 421 | ESLA | Estrella Immunopharma, Inc. | 55.46M | -7.60% | 51,497 | - |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 55.11M | 14.58% | 252,391 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 54.52M | 0.54% | 132,722 | - |
| 424 | TIL | Instil Bio, Inc. | 54.32M | 2.30% | 70,542 | - |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 53.84M | 1.42% | 181,903 | 25.21M |
| 426 | LIXT | Lixte Biotechnology Holdings, Inc. | 51.12M | -1.90% | 99,643 | - |
| 427 | ATOS | Atossa Therapeutics, Inc. | 49.95M | 3.94% | 60,166 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 48.73M | -7.41% | 63,435 | 10.86M |
| 429 | NTRB | Nutriband Inc. | 48.26M | -2.70% | 14,168 | 2.04M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 0.75% | 130,279 | - |
| 431 | DARE | Daré Bioscience, Inc. | 46.01M | -3.36% | 1,578,939 | 1.03M |
| 432 | XLO | Xilio Therapeutics, Inc. | 45.68M | 2.46% | 19,605 | 43.77M |
| 433 | ATRA | Atara Biotherapeutics, Inc. | 43.84M | 8.19% | 185,370 | 120.77M |
| 434 | LITS | Lite Strategy, Inc. | 43.27M | 4.39% | 657,723 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 41.47M | -22.06% | 2,459,728 | 813.46K |
| 436 | PSTV | Plus Therapeutics, Inc. | 41.17M | -3.54% | 175,947 | 5.21M |
| 437 | INMB | INmune Bio Inc. | 40.41M | -1.30% | 409,212 | 50.00K |
| 438 | RNXT | RenovoRx, Inc. | 40.09M | -4.14% | 285,874 | 1.12M |
| 439 | ALGS | Aligos Therapeutics, Inc. | 39.42M | 0.31% | 150,995 | 2.19M |
| 440 | NXTC | NextCure, Inc. | 38.67M | 15.02% | 84,168 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 38.66M | -1.59% | 147,949 | 90.00K |
| 442 | MREO | Mereo BioPharma Group plc | 37.86M | -14.89% | 2,413,243 | 500.00K |
| 443 | PTN | Palatin Technologies, Inc. | 37.00M | -5.00% | 67,569 | 8.96M |
| 444 | EVAX | Evaxion A/S | 36.78M | 0.23% | 9,414 | 7.53M |
| 445 | GRCE | Grace Therapeutics, Inc. | 36.67M | 1.72% | 1,412,247 | - |
| 446 | VERU | Veru Inc. | 35.63M | 0.45% | 72,797 | 16.89M |
| 447 | CRVO | CervoMed Inc. | 35.46M | 2.68% | 25,791 | 4.01M |
| 448 | BOLD | Boundless Bio, Inc. | 35.42M | 0.64% | 84,766 | - |
| 449 | SNSE | Sensei Biotherapeutics, Inc. | 34.88M | 0.62% | 22,189 | - |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 34.34M | -0.81% | 34,882 | - |
| 451 | APLM | Apollomics, Inc. | 33.47M | -4.75% | 3,231 | 8.84M |
| 452 | PLUR | Pluri Inc. | 33.17M | - | 18,300 | 1.34M |
| 453 | NRSN | NeuroSense Therapeutics Ltd. | 31.74M | -5.46% | 445,441 | - |
| 454 | HOWL | Werewolf Therapeutics, Inc. | 31.60M | -2.91% | 307,857 | 1.14M |
| 455 | NNVC | NanoViricides, Inc. | 31.53M | - | 211,109 | - |
| 456 | IGC | IGC Pharma, Inc. | 31.44M | -1.24% | 549,681 | 1.11M |
| 457 | QNTM | Quantum BioPharma Ltd. | 31.02M | -1.49% | 207,637 | - |
| 458 | SNTI | Senti Biosciences Holdings, Inc. | 30.25M | 1.82% | 108,403 | 22.00K |
| 459 | BCTX | BriaCell Therapeutics Corp. | 29.97M | 1.97% | 204,459 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 29.89M | -3.01% | 190,753 | - |
| 461 | LSTA | Lisata Therapeutics, Inc. | 29.45M | -0.31% | 43,838 | 170.00K |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 29.44M | -4.07% | 8,698 | - |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 29.00M | -0.37% | 27,510 | 14.99M |
| 464 | TPST | Tempest Therapeutics, Inc. | 28.97M | -6.05% | 246,062 | - |
| 465 | KYNB | Kyntra Bio, Inc. | 28.82M | 0.28% | 4,403 | 6.44M |
| 466 | DYAI | Dyadic International, Inc. | 27.70M | -1.30% | 17,122 | 3.09M |
| 467 | SER | Serina Therapeutics, Inc. | 27.26M | 1.67% | 44,393 | 130.00K |
| 468 | ABVC | ABVC BioPharma, Inc. | 27.18M | 6.80% | 160,095 | 797.92K |
| 469 | BRNS | Barinthus Biotherapeutics plc | 26.86M | 0.38% | 41,929 | 14.97M |
| 470 | PLRZ | Polyrizon Ltd. | 26.83M | 1.38% | 12,876 | - |
| 471 | CELU | Celularity Inc. | 26.82M | -2.40% | 29,069 | 26.55M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 26.51M | -2.02% | 274,743 | - |
| 473 | LGVN | Longeveron Inc. | 25.59M | 2.09% | 403,025 | 1.20M |
| 474 | CRIS | Curis, Inc. | 24.66M | 8.17% | 225,044 | 9.44M |
| 475 | MRKR | Marker Therapeutics, Inc. | 24.34M | -3.31% | 79,448 | 3.55M |
| 476 | OTLK | Outlook Therapeutics, Inc. | 24.25M | -4.10% | 7,549,506 | 205.70K |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 24.19M | 1.72% | 238,553 | 789.00K |
| 478 | LTRN | Lantern Pharma Inc. | 23.99M | -0.93% | 130,761 | - |
| 479 | AEON | AEON Biopharma, Inc. | 22.91M | -2.11% | 61,970 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 22.88M | 5.71% | 560,261 | 320.00K |
| 481 | VYNE | VYNE Therapeutics Inc. | 22.31M | 0.53% | 189,645 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.61M | -0.29% | 11,019 | 500.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 21.20M | -0.01% | 231,831 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 19.89M | -0.81% | 736,179 | - |
| 485 | LPCN | Lipocine Inc. | 19.50M | 4.29% | 157,965 | 1.98M |
| 486 | ICU | SeaStar Medical Holding Corporation | 19.45M | 10.18% | 165,284 | 1.23M |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.44M | 2.17% | 137,898 | - |
| 488 | OSRH | OSR Holdings, Inc. | 19.34M | 12.72% | 3,304,014 | 2.91M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 18.99M | -2.37% | 90,544 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 18.06M | -3.00% | 692,933 | 3.94M |
| 491 | TOVX | Theriva Biologics, Inc. | 17.53M | 0.50% | 2,218,500 | 300.00K |
| 492 | TRAW | Traws Pharma, Inc. | 17.27M | 7.59% | 136,348 | 2.79M |
| 493 | LEXX | Lexaria Bioscience Corp. | 16.72M | -2.68% | 155,444 | 368.00K |
| 494 | GNTA | Genenta Science S.p.A. | 16.28M | 2.97% | 113,519 | - |
| 495 | GRDX | GridAI Technologies Corp. | 15.87M | 4.49% | 48,299 | - |
| 496 | INAB | IN8bio, Inc. | 15.56M | -2.47% | 74,710 | - |
| 497 | HIND | Vyome Holdings, Inc. | 15.44M | 6.28% | 31,197 | 319.71K |
| 498 | NCEL | NewcelX Ltd. | 15.13M | -7.52% | 80,248 | - |
| 499 | CLRB | Cellectar Biosciences, Inc. | 14.97M | 11.01% | 1,931,493 | - |
| 500 | BLRX | BioLineRx Ltd. | 14.39M | 10.20% | 71,963 | 1.18M |